These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14776993)

  • 21. [Case of agranulocytosis occurring during mesantoin therapy of epilepsy].
    RIGOTTI S
    Riv Neurol; 1951; 21(6):532-8. PubMed ID: 14942315
    [No Abstract]   [Full Text] [Related]  

  • 22. Mesantoin in the management of the hospitalized psychotic epileptic; report of toxic effects and one fatality.
    HOFSTATTER L
    South Med J; 1951 Sep; 44(9):827-32. PubMed ID: 14866529
    [No Abstract]   [Full Text] [Related]  

  • 23. Mesantoin in the treatment of convulsive disorders.
    LITTLJOHN WS; LITTLE SC; McLALLEN CD
    Dis Nerv Syst; 1951 Sep; 12(9):269-73. PubMed ID: 14887566
    [No Abstract]   [Full Text] [Related]  

  • 24. [DATA TO THE PROBLEM OF CHRONIC MESANTOIN POISONING].
    GRIESSHABER W
    Med Klin; 1964 Jun; 59():932-4. PubMed ID: 14234232
    [No Abstract]   [Full Text] [Related]  

  • 25. THE TREATMENT OF EPILEPSY WITH METHYLPHENYLETHYL HYDANTOIN (MESANTOIN).
    Aird RB
    Calif Med; 1948 Mar; 68(3):141-6. PubMed ID: 18731395
    [No Abstract]   [Full Text] [Related]  

  • 26. The control with mesantoin on convulsive seizures due to neurosyphilis; clinical and electroencephalographic studies.
    WONG YT; HAYS AL; HILL TS
    J Nerv Ment Dis; 1952 Sep; 116(3):189-97. PubMed ID: 12991075
    [No Abstract]   [Full Text] [Related]  

  • 27. [Granulocytopenic syndromes in mesantoin therapy].
    BELSASSO M; BONIVENTO M
    Minerva Med; 1952 Oct; 43(79):558-62. PubMed ID: 13013023
    [No Abstract]   [Full Text] [Related]  

  • 28. MESANTOIN LYMPHADENOPATHY MORPHOLOGICALLY SIMULATING HODGKIN'S DISEASE.
    DOYLE AP; HELLSTROM HR
    Ann Intern Med; 1963 Sep; 59():363-8. PubMed ID: 14065954
    [No Abstract]   [Full Text] [Related]  

  • 29. Changes in the electroencephalogram following administration o mesantoin (methyl-phenyl-ethyl hydantoin).
    LITTLE SC; McAVOY M
    Electroencephalogr Clin Neurophysiol; 1949 Aug; 1(3):325-32. PubMed ID: 18135424
    [No Abstract]   [Full Text] [Related]  

  • 30. Aplasia of the bone marrow during mesantoin therapy; report of a fatal case.
    WITKIND E; WAID ME
    J Am Med Assoc; 1951 Oct; 147(8):757-9. PubMed ID: 14873554
    [No Abstract]   [Full Text] [Related]  

  • 31. Occurrence of skin pigmentation during mesantoin therapy.
    HUNTER H; JENKINS D
    J Am Med Assoc; 1951 Oct; 147(8):744-8. PubMed ID: 14873548
    [No Abstract]   [Full Text] [Related]  

  • 32. Mesantoin, a new anticonvulsant in the management of epilepsy; a preliminary report.
    CARTER HR
    Rocky Mt Med J; 1947 Aug; 44(8):614-6. PubMed ID: 20255912
    [No Abstract]   [Full Text] [Related]  

  • 33. Generalized lymphadenopathy and nephrotic syndrome as a manifestation of mephenytoin (mesantoin) toxicity.
    Snead C; Siegel N; Hayslett J
    Pediatrics; 1976 Jan; 57(1):98-101. PubMed ID: 1246508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatal granulocytopenia following hydantoins, mesantoin and dilantin; report of a case.
    BERNHARDT H
    J Med Assoc State Ala; 1950 Jan; 19(7):193-7. PubMed ID: 15408514
    [No Abstract]   [Full Text] [Related]  

  • 35. Mesantoin toxicity; a clinical note.
    GARVIN JS; GIBBS FA
    Dis Nerv Syst; 1950 Feb; 11(2):48-50. PubMed ID: 15403510
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hypersensitivity reaction produced by the administration of mesantoin, which simulated Hodgkin's lymphoma].
    Romero García F; Reynaga Sánchez R; Wolburg López J
    Rev Invest Clin; 1967; 19(1):51-8. PubMed ID: 5317594
    [No Abstract]   [Full Text] [Related]  

  • 37. [Complications of electro-convulsontherapy caused by mesantoin].
    ROMPEL H
    S Afr Med J; 1951 Jul; 25(27):465-8. PubMed ID: 14866478
    [No Abstract]   [Full Text] [Related]  

  • 38. [Injurious effects of mesantoin].
    KEIBL E; MAYR HO; NEUHOLD R
    Wien Med Wochenschr; 1951 Jun; 101(23):426-9. PubMed ID: 14867348
    [No Abstract]   [Full Text] [Related]  

  • 39. Pancytopenia due to mesantoin: report of a case.
    DAVIES RR; FISCH C; TISCHER EP
    N Engl J Med; 1950 Jun; 242(22):863-4. PubMed ID: 15416914
    [No Abstract]   [Full Text] [Related]  

  • 40. [A case of scarlatinoform dermatitis produced by mesantoin administration].
    DANIEL MARTINEZ P; GOMEZ OROZCO L
    Bol Med Hosp Infant Mex; 1950 Dec; 7(6):884-6. PubMed ID: 14848169
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.